Ticker: ABEO

Abeona Therapeutics Inc. (NASDAQ: ABEO) - What's happening inside the company Abeona received FDA approval for ZEVASKYN™ on April 28, 2025, sold the associated Priority Review Voucher (PRV) for gross proceeds of $155.0 million (closed June 27, 2025), has established cGMP commercial manufacturing ...